Medscape – In a wide-ranging hearing on Thursday, the US Senate Committee on Health, Education, Labor and Pensions questioned Francis Collins, MD, director of the National Institutes of Health (NIH), and Scott Gottlieb, MD, commissioner of the US Food and Drug Administration (FDA), on the progress they have made in implementing the 21st Century Cures Act in the year since the legislation was passed.
While the tone of the hearing was mostly upbeat and congratulatory, some Democratic senators raised the same questions about funding for the Cures Act implementation that arose in the recent House subcommittee hearing on the same subject.
Dr Collins and Dr Gottlieb said that the law has helped their agencies more quickly push forward medical research and approve new therapies, respectively. This acceleration is especially important, they said, at a time when researchers are making rapid advances in such fields as gene therapy, regenerative medicine, and precision medicine.
Read more at Medscape.